<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>Bookmarks by </title>
      <link>https://padlet.com/nataliamartinezvanegas/Bookmarks</link>
      <description>Made with charm</description>
      <language>en-us</language>
      <pubDate>2022-03-02 14:02:24 UTC</pubDate>
      <lastBuildDate>2022-03-02 17:11:03 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url></url>
      </image>
      <item>
         <title>Autonomic Nervous System (ANS) visceral</title>
         <author>nataliamartinezvanegas</author>
         <link>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073621468</link>
         <description><![CDATA[<div>-Involuntary control<br>-Branches of cranial and spinal motor innervate ( Cardiac and smooth muscle of internal organs and glands)<br>-Regulated by hypothalamus and medulla oblongata<br>-Autorhythmicity<br>-Homeostasis regulation<br><br><strong><mark>ANS Subdivision:</mark></strong><br><strong>1. Sympathetic Nervous System (Adrenergic)<br>2. Parasympathetic Nervous System (Cholinergic)</strong><br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2022-03-02 14:07:23 UTC</pubDate>
         <guid>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073621468</guid>
      </item>
      <item>
         <title>1. Sympathetic Nervous System = Adrenergic</title>
         <author>nataliamartinezvanegas</author>
         <link>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073626233</link>
         <description><![CDATA[<div><br>Fight, Fright, Flight<br><br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2022-03-02 14:09:08 UTC</pubDate>
         <guid>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073626233</guid>
      </item>
      <item>
         <title>2. Parasympathetic Nervous System = Cholinergic</title>
         <author>nataliamartinezvanegas</author>
         <link>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073627962</link>
         <description><![CDATA[<div><br>Rest and Digest</div>]]></description>
         <enclosure url="" />
         <pubDate>2022-03-02 14:09:56 UTC</pubDate>
         <guid>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073627962</guid>
      </item>
      <item>
         <title>1.1 Adrenergic Neurotransmitters </title>
         <author>nataliamartinezvanegas</author>
         <link>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073642168</link>
         <description><![CDATA[<div>Acetylcholine (ACH)  ---&gt;  at ganglion<br>Norepinephrine (NE) ---&gt; at postganglionic nerve endings<br>Epinephrine (EPI) <br>Dopamine (DA)<br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1608480225/a658a4b25812c2af8218d0626b2dc99d/image.png" />
         <pubDate>2022-03-02 14:16:12 UTC</pubDate>
         <guid>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073642168</guid>
      </item>
      <item>
         <title>2.1 Cholinergic Neurotransmitter</title>
         <author>nataliamartinezvanegas</author>
         <link>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073649378</link>
         <description><![CDATA[<div>Acetylcholine(ACH) --- &gt; at ganglion, at postganglionic nerve endings</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1608480225/9c57ce2e34ae147a3b9cbf65486a62dd/image.png" />
         <pubDate>2022-03-02 14:19:22 UTC</pubDate>
         <guid>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073649378</guid>
      </item>
      <item>
         <title>1.2 Adrenergic Receptors</title>
         <author>nataliamartinezvanegas</author>
         <link>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073673973</link>
         <description><![CDATA[<div><br><strong>Alpha-1: </strong>Most arteries and veins, glands, eyes, smooth muscle<br><strong>Alpha-2:</strong> Adrenergic nerve ending (Parasympathetic response)<br><strong>Beta-1:</strong> Heart<br><strong>Beta-2: </strong>Lungs, coronary and skeletal muscle blood vessels<br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2022-03-02 14:30:14 UTC</pubDate>
         <guid>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073673973</guid>
      </item>
      <item>
         <title>2.2 Cholinergic Receptors</title>
         <author>nataliamartinezvanegas</author>
         <link>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073684163</link>
         <description><![CDATA[<div><strong>Muscarinic:</strong> Cardiac, smooth muscle, and glands at the parasympathetic postganglionic nerve ending.<br><strong>Nicotinic 1 (Nn):</strong> At ganglia of parasympathetic nerves and Sympathetic nerves ( synapse area)<br><strong>Nicotinic 2 (Nm): </strong>Somatic neuromuscular junctions (NMJ) skeletal muscle&nbsp;</div>]]></description>
         <enclosure url="" />
         <pubDate>2022-03-02 14:34:42 UTC</pubDate>
         <guid>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073684163</guid>
      </item>
      <item>
         <title>1.3 Effect from sympathetic Stimulation</title>
         <author>nataliamartinezvanegas</author>
         <link>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073710572</link>
         <description><![CDATA[<div><strong>Adrenal medulla</strong> ---&gt; Release epinephrine<br><strong>Arteries</strong> ------------&gt; Vasoconstriction (<strong>except</strong> the coronary arteries and arteries to skeletal muscle, which are dilated)<br><strong>Heart</strong>--------------&gt;Increase conduction and contractility<br><strong>Postganglionic NT</strong> --&gt; Norepinephrine released<br><strong>Pupil of eye</strong> -------&gt; Mydriasis (dilation)<br><strong>Respiratory passages, lower</strong>--&gt; Bronchodilation<br><br><strong>GI motility, and secretions</strong>--&gt; Decreased<br><strong>Urinary bladder</strong>-------------&gt; Relaxation<br><strong>Urinary sphincter</strong>------------&gt; Contraction</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1608480225/d57ac698ac859ef3725b2c6af4adff92/image.png" />
         <pubDate>2022-03-02 14:46:54 UTC</pubDate>
         <guid>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073710572</guid>
      </item>
      <item>
         <title>2.3 Effect from Parasympathetic Stimulation</title>
         <author>nataliamartinezvanegas</author>
         <link>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073736592</link>
         <description><![CDATA[<div><strong>Adrenal medulla</strong> ---&gt; None<br><strong>Arteries</strong> ------------&gt; Most arteries <strong>are not supplied</strong> by parasympathetic nerves<br><strong>Heart</strong>--------------&gt;Decreases conduction and a slight decrease in contractility<br><br><strong>GI motility, and secretions</strong>--&gt; Increased<br><strong>Postganglionic NT</strong> --&gt; Acetylcholine released<br><strong>Pupil of eye</strong> -------&gt; Miosis ( constriction)-smaller<br><strong>Respiratory passages, lower</strong>--&gt; Bronchoconstriction<br><strong>Urinary bladder</strong>-------------&gt; Contraction<br><strong>Urinary sphincter</strong>------------&gt; Relaxation</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1608480225/81de6831c313d40eb1d38df0cdf40426/image.png" />
         <pubDate>2022-03-02 14:58:35 UTC</pubDate>
         <guid>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073736592</guid>
      </item>
      <item>
         <title>1.4 Sympathomimetics: mimic the sympathetic system  (Adrenergics, Agonists)</title>
         <author>nataliamartinezvanegas</author>
         <link>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073817984</link>
         <description><![CDATA[<div><strong><mark>1. Alpha-1 Adrenergic Agonists</mark></strong><br><strong>Alpha-1</strong> <strong>receptor is stimulated</strong><br><strong>Action:</strong> contraction of smooth muscle, blood vessels constrict, increases BP <br>vasoconstriction of nasal passages - decongestant effect<br><br> *ephedrine-increases BP<br> *phenylephrine (Neo-Synephrine®)<br><br><br><strong><mark>2. Adrenergic Agonists</mark></strong><br><strong>Stimulates all alpha and beta receptors</strong><br><strong>Action: </strong>Vasopressor-vasoconstriction, increases BP<br>Cardiac stimulant<br>Bronchodilator<br><br>&nbsp;*epinephrine (Adrenalin®)<br><br><strong><mark>3. Beta-Adrenergic Agonists</mark></strong><br><strong>Beta -1 Adrenergic Agonists</strong><br><strong>Low dose:</strong> dopaminergic (d-1) receptors in kidneys vasodilation/ increased renal blood flow<br><strong>Moderate dose:</strong> beta 1 receptors-heart, increases the force of contraction and cardiac output <br><strong>High dose:</strong> alpha-1 receptors causing vasoconstriction increase blood pressure<br><br> *dobutamine<br><br><strong><mark>4. Beta-2 Adrenergic Agonists</mark></strong><br><strong>Stimulates beta 2 receptors</strong> <br><strong>Action:</strong> Relaxation of the smooth muscle of the uterus and the lungs (bronchodilation)<br><br> *formoterol (Foradil®)<br> *albuterol (Proventil®, Ventolin®)<br> *terbutaline (Brethine®)&nbsp;<br> *salmeterol (Serevent®)</div>]]></description>
         <enclosure url="" />
         <pubDate>2022-03-02 15:36:03 UTC</pubDate>
         <guid>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073817984</guid>
      </item>
      <item>
         <title>1.5 Sympatholytics: works against the sympathetic system (Adrenergic blocking, blockers, Inhibitors, Antagonists)</title>
         <author>nataliamartinezvanegas</author>
         <link>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073824140</link>
         <description><![CDATA[<div><strong><mark>1. Alpha-1 Adrenergic Blocking Drugs</mark></strong><br><strong>Binds to alpha-1 receptors and blocks them</strong><br><strong>Action: </strong>Relaxation of smooth muscle and ureters,<br>vasodilation of blood vessels, decreases BP<br><br>&nbsp;*prazosin (Minipress®)<br>&nbsp;*terazosin (Hytrin®) <br>&nbsp;*doxazosin (Cardura®)<br><br><strong><mark>2. Beta-Adrenergic Blocking Drugs</mark></strong><br>&nbsp; &nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; <strong><mark>2.1 Selective Beta-1 Blockers</mark></strong><br><strong>Beta-1 receptor is blocked </strong><br><strong>Action:</strong> Decreases force of contraction(- inotropic), decreases HR(- chronotropic), decreases conduction(- dromotropic), decrease in cardiac output, decreases BP<br><br> *atenolol (Tenormin®)<br> *metoprolol (Lopressor®)<br><br>&nbsp; &nbsp; &nbsp;<strong>&nbsp; &nbsp;</strong><strong><mark>2.2 Non-selective Beta Blockers </mark></strong><br><strong>block beta-1 and beta-2 receptors </strong><br><strong>Action: </strong>Decreases force of contraction(- inotropic), decreases HR(- chronotropic), decreases conduction(- dromotropic), decrease in cardiac output, decreases BP, and can cause bronchoconstriction&nbsp;<br><br>&nbsp;*nadolol (Corgard®)<br>&nbsp;*propanolol (Inderal®)&nbsp;<br>&nbsp;*timolol (Blocadren®)<br><br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2022-03-02 15:38:53 UTC</pubDate>
         <guid>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073824140</guid>
      </item>
      <item>
         <title>2.4 Parasympathomimetics: mimic parasympathetic system (Agonists, Cholinergics)</title>
         <author>nataliamartinezvanegas</author>
         <link>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073858959</link>
         <description><![CDATA[<div><br><strong><mark>1. Direct–Acting Cholinergic Agonists</mark></strong><br><strong>Directly stimulate/bind to the muscarinic receptors</strong> in the parasympathetic division, mimics ACH<br><strong>Action: </strong>Pupil constriction, decreases intraocular pressure, prevent constipation and urinary retention post-op<br><br>&nbsp;*acetylcholine<br>&nbsp;*pilocarpine (Pilocar<strong>®</strong> )<br> *bethanechol (Urecholine<strong>®</strong>)<br><br><br><strong><mark>2. Indirect –Acting Cholinergic Agonists</mark></strong><br><strong>inhibit acetylcholinesterase,</strong> the enzyme that <strong>destroys ACH</strong> in the synapse<br><strong>Action:</strong> increases ACH<br><br> *neostigmine (Prostigmin®)</div>]]></description>
         <enclosure url="" />
         <pubDate>2022-03-02 15:55:53 UTC</pubDate>
         <guid>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073858959</guid>
      </item>
      <item>
         <title>2.5 Parasympatholytics: against parasympathetic system (Antagonists, Anticholingerics)</title>
         <author>nataliamartinezvanegas</author>
         <link>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073861945</link>
         <description><![CDATA[<div><strong><mark>1. Anticholinergics</mark></strong><br><strong>Bind to a cholinergic receptor</strong> <br><strong>Action:</strong> Acts as a blocking drug; Competitive antagonism<br><br> *atropine<br> *dicyclomine (Bentyl®)<br> *ipratropium bromide (Atrovent®)<br><br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2022-03-02 15:57:16 UTC</pubDate>
         <guid>https://padlet.com/nataliamartinezvanegas/Bookmarks/wish/2073861945</guid>
      </item>
   </channel>
</rss>
